Table 1. Baseline characteristics of 65 patients.
| Characteristics | No |
| Sex (male/female) | 50/15 |
| Median age, y (range) | 66 (39 – 89) |
| Histology | |
| Adenocarcinoma | 37 (57 %) |
| Squamous cell carcinoma | 26 (40 %) |
| Other | 2 (3 %) |
| Location | |
| Proximal esophagus | 4 (6 %) |
| Mid esophagus | 20 (31 %) |
| Distal esophagus | 34 (52 %) |
| Gastric tube after esophageal resection | 7 (11 %) |
| Indication SEMS insertion | |
| Stenosis | 59 (91 %) |
| Stenosis with fistula | 6 (9 %) |
| Dysphagia score | |
| Grade 2 (able to eat semi-solid foods) | 5 (9 %) |
| Grade 3 (able to swallow liquids only) | 41 (60 %) |
| Grade 4 (unable to swallow anything) | 19 (31 %) |
| Type of SEMS | |
| Boston Ultraflex (pc1) (small body) | 18 (28 %) |
| Cook Evolution (pc1) (wide body) | 14 (21 %) |
| M.I. Tech Hanaro stent (fc2) (small body) | 9 (14 %) |
| Boston Wallflex (fc2) (small body) | 10 (15 %) |
| Boston Wallflex (pc1) (small body) | 14 (22 %) |
| Pretreatment | 46 (71 %) |
| Chemotherapy | 16 (25 %) |
| Radiotherapy | 3 (4 %) |
| Chemo/radiotherapy | 23 (34 %) |
| Brachytherapy | 5 (8 %) |
1
Partially covered.
2
Fully covered.